L S Lamb

Summary

Publications

  1. ncbi Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease
    L S Lamb
    Division of Transplantation Medicine, Palmetto Richland Memorial Hospital, Center for Cancer Treatment and Research, University of South Carolina School of Medicine, Columbia, South Carolina
    Cytometry 38:238-43. 1999
  2. ncbi Influence of T cell depletion method on circulating gammadelta T cell reconstitution and potential role in the graft-versus-leukemia effect
    L S Lamb
    Division of Transplantation Medicine, Palmetto Richland Memorial Hospital, Center for Cancer Treatment and Research, University of South Carolina School of Medicine, Columbia, South Carolina 29203, USA
    Cytotherapy 1:7-19. 1999
  3. ncbi CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery
    W B Lindsey
    South Carolina Cancer Center, Columbia, South Carolina, USA
    Cytotherapy 9:123-32. 2007

Collaborators

Detail Information

Publications3

  1. ncbi Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease
    L S Lamb
    Division of Transplantation Medicine, Palmetto Richland Memorial Hospital, Center for Cancer Treatment and Research, University of South Carolina School of Medicine, Columbia, South Carolina
    Cytometry 38:238-43. 1999
    ..Cytometry (Comm. Clin. Cytometry) 38: 238-243, 1999...
  2. ncbi Influence of T cell depletion method on circulating gammadelta T cell reconstitution and potential role in the graft-versus-leukemia effect
    L S Lamb
    Division of Transplantation Medicine, Palmetto Richland Memorial Hospital, Center for Cancer Treatment and Research, University of South Carolina School of Medicine, Columbia, South Carolina 29203, USA
    Cytotherapy 1:7-19. 1999
    ..091). DISCUSSION: These observations indicate that Vdelta1+CD4-CD8-cytotoxic T cells are associated with lower relapse rates and improved survival, and thus may have a role in a graft-versus-leukemia effect...
  3. ncbi CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery
    W B Lindsey
    South Carolina Cancer Center, Columbia, South Carolina, USA
    Cytotherapy 9:123-32. 2007
    ..Quantitative flow cytometric determination of CD69 expression on T lymphocytes has several advantages over traditional lymphocyte proliferation assays, but this method has not yet been standardized for clinical applications...